Intraosseous Pressure Monitoring in Intensive Care Unit Patients

H

HealthPartners Institute

Status

Completed

Conditions

Blood Pressure

Treatments

Device: Intraosseous Device

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02059928
13-149

Details and patient eligibility

About

In emergency situations, access to the venous system is essential in order to administer fluids and medication and to monitor patients. When peripheral veins are difficult to access or the patient's condition requires certain medications, or monitoring, central venous catheters (CVC) are inserted. CVC placement introduces a much higher level of risk compared to peripheral catheters. The technique of intraosseous (IO) infusion has been used by healthcare professionals for several decades, but recently has gained wide popularity in the emergency care settings. This technique allows providers to secure a needle in the bony matrix at the ends of long bones (tibia and humerus) and infuse fluids and medications into the intramedullary space. The ability to monitor a patient's blood pressure through an intraosseous needle is unknown. The primary objective of this study is to describe the relationship (ratio) of intraosseous pressure (IOP) values to standard pressure values, including systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and central venous pressure (CVP).

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥ 18 years old
  • Admitted to the surgical intensive care units
  • Current central pressure monitoring through a central line
  • Patient currently intubated and sedated
  • Informed consent obtained from family member
  • English speaking patient

Exclusion criteria

  • Known implanted devices in the humerus or tibia that prohibit placement of the intraosseous needle.
  • Known osteoporosis, avascular necrosis, or other bone pathology affecting bone healing.
  • Fracture or other significant injury to the tibia or humerus or surrounding musculature/tissue.
  • Inability to landmark IO placement due to excessive tissue over placement location.
  • Anticipated surgery within 12 hours of time of consent
  • Current infection at the placement site.
  • Previous, significant orthopedic procedure at the site
  • Pregnant or has the potential for being pregnant
  • Prisoner of the state
  • Minor (< 18 years old)
  • Inability to obtain informed consent from family member
  • Non-English speaking patient

Trial design

20 participants in 1 patient group

Intraosseous device placement
Experimental group
Description:
Intraosseous device
Treatment:
Device: Intraosseous Device

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems